For over three decades, IEM has been a reliable ally of the pharmaceutical sector, biotech firms, CROs, and academic institutions in the realm of managing hypertension during clinical trials. Our array of offerings encompasses the complete spectrum of screening, diagnostics, and remote patient therapy follow-up via telemedicine (DCT), alongside comprehensive data management solutions.